Your session is about to expire
← Back to Search
Azithromycin for COVID-19
Study Summary
This trial will study the efficacy of a new treatment for a disease.
- COVID-19
- Coronavirus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have allergies to the study drugs. You have conditions that make it unsafe for you to take the study drugs, such as retinopathy or prolonged QTc interval (heart rhythm). You have advanced kidney disease or are receiving dialysis. You have a condition called glucose-6-phosphate dehydrogenase (G6PD) deficiency.
- Group 1: Hydroxychloroquine and Azithromycin
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 30 Other Conditions - This treatment demonstrated efficacy for 30 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What type of ailments are usually addressed with Azithromycin?
"Azithromycin is an effective solution for the treatment of genital ulcer disease (GUD) and other afflictions, such as Q fever, chlamydia infections, and adult patients."
Is enrollment for this clinical experiment still open to new participants?
"At this juncture, patient recruitment for the trial discussed has concluded. It was initially advertised on March 24th 2020 and last refreshed June 30th 2020. Alternatively, 1029 trials recruiting patients with Covid-19 are still actively enrolling while 115 studies related to Azithromycin have open slots available."
What other experiments have been conducted using Azithromycin as a focal point?
"Presently, 115 studies are being conducted with Azithromycin. Out of these, 23 have advanced to Phase 3 and 1464 sites across the globe are research centers for this particular drug. Hangzhou in Zhejiang has hosted the majority of trials thus far."
Has Azithromycin been granted regulatory authorization by the FDA?
"There is a limited amount of data suggesting Azithromycin's safety, so it was scored 2 out of 3."
What is the total size of the population currently participating in this research endeavor?
"Unfortunately, this clinical trial is no longer seeking enrolment. It was initially posted on March 24th 2020 and the last data update occurred by June 30th 2020. However, there are still 1029 studies available for those afflicted with Covid-19 and 115 trials accepting Azithromycin participants."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger